The mast cell as site of tissue-type plasminogen activator expression and fibrinolysis

Journal of Immunology

Volumn 162, Issue 2, 1999, Pages 1032-1041

  Sillaber, Christian ^a   Baghestanian, Mehrdad ^a   Bevec, Dorian ^b   Willheim, Martin ^c   Agis, Hermine ^a   Kapiotis, Stylianos ^a   Füreder, Wolfgang ^a   Bankl, Hans C ^c   Kiener, Hans P ^a   Speiser, Wolfgang ^a   Binder, Bernd R ^a   Lechner, Klaus ^a   Valent, Peter ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b NOVARTIS PHARMA AG   (Switzerland)

^c UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

TISSUE PLASMINOGEN ACTIVATOR;

ARTICLE; BLOOD CLOTTING; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME INDUCTION; FIBRINOLYSIS; HUMAN; HUMAN CELL; IMMUNOASSAY; IMMUNOBLOTTING; MAST CELL; NORTHERN BLOTTING; PRIORITY JOURNAL;

CELL LINE; CELLS, CULTURED; ENDOTHELIUM, VASCULAR; FIBRINOLYSIS; HUMANS; IMMUNOHISTOCHEMISTRY; LUNG; MAST CELLS; MUSCLE, SMOOTH, VASCULAR; PLASMINOGEN ACTIVATOR INHIBITOR 1; RNA, MESSENGER; TISSUE PLASMINOGEN ACTIVATOR; UMBILICAL VEINS;

EID: 0033555724     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (77)

1. Dano, K., P. A. Andreasen, J. Grondahl-Hansen, P. Kristensen, L. S. Nielsen, and L. Skriver. 1985. Plasminogen activators, tissue degradation, and cancer. Adv. Cancer Res. 44:139.
2. Collen, D., and H. R. Lijnen. 1991. Basic and clinical aspects of fibrinolysis and thrombolysis. Blood 78:3114.
3. Vassalli, J. D., A. P. Sappino, and D. Belin. 1991. The plasminogen activator/plasmin system. J. Clin. Invest. 83:1067.
4. Bachmann, F. 1994. Molecular aspects of plasminogen, plasminogen activators and plasmin. In Haemostasia and Thrombosis, Vol. 3. A. L. Bloom, C. D. Forbes, D. P. Thomas, and E. G. D. Tuddenham, eds. Churchill Livingston, Edinburgh, p. 575.
5. Blasi, F., J. D. Vassalli, and K. Dano. 1987. Urokinase-type plasminogen activator: proenzyme, receptor, and inhibitors. J. Cell Biol. 104:801.
6. Carmeliet, P., L. Schoonjans, L. Kieckens, B. Ream, J. Degen, R. Bronson, R. De Vos, J. J. van den Oord, D. Collen, and R. C. Mulligan. 1994. Physiological consequences of loss of plasminogen activator gene function in mice. Nature 368:419.
7. Neuhaus, K. L., U. Tebbe, M. Gottwik, M. A. J. Weber, W. Feurer, W. Niederer, W. Haerer, F. Praetorius, K. D. Grosser, W. Huhmann, et al. 1988. Intravenous recombinant tissue plasminogen activator (rt-PA) and urokinase in acute myocardial infarction: results of the German activator urokinase study (GAUS). J. Am. Coll. Cardiol. 12:581.
8. Kruithof, E. K. O. 1988. Plasminogen activator inhibitors: a review. Enzyme 40:113.
9. Stump, D., M. Thienpoint, and D. Collen. 1986. Purification and characterization of a novel inhibitor of urokinase from human urine: quantitation and preliminary characterization in plasma. J. Biol. Chem. 261:12759.
10. Dawson, S., and A. Henney. 1992. The status of PAI-1 as a risk factor for arterial and thrombotic disease: a review. Atherosclerosis 95:105.
11. van Hinsbergh, V. W. 1988. Regulation of synthesis and secretion of plasminogen activators by endothelial cells. Haemostasis 18:307.
12. Pearson, J.D. 1993. The control of production and release of haemostatic factors in the endothelial cell. Baillieres Clin. Haematol. 6:629.
13. Shih, G. C., and K. A. Haijar. 1993. Plasminogen and plasminogen activator assembly on human endothelial cells. Proc. Soc. Exp. Biol. Med. 202:258.
14. Wojta, J., H. Zoellner, M. Gallicchio, J. A. Hamilton, and K. McGrath. 1992. γ Interferon counteracts interleukin-1α stimulated expression of urokinase-type plasminogen activator in human endothelial cells in vitro. Biochem. Biophys. Res. Commun. 188:463.
15. Christ, G., D. Seiffert, P. Hufnagl, A. Gessl, J. Wojta, and B. R. Binder. 1993. Type 1 plasminogen activator inhibitor synthesis of endothelial cells is down-regulated by smooth muscle cells. Blood 81:1277.
16. Bartha, K., P. J. Declerck, H. Moreau, L. Nelles, and D. Collen. 1991. Synthesis and secretion of plasminogen activator inhibitor 1 by human endothelial cells in vitro: effect of active site mutagenized tissue type plasminogen activator. J. Biol. Chem. 266:792.
17. Lundgren, C. H., H. Sawa, B. E. Sobel, and S. Fujii. 1994. Modulation of expression of monocyte/macrophage plasminogen activator activity and its implication for attenuation of vasculopathy. Circulation 90:1927.
18. Chapman, H. A., Z. Vavrin, and J. B. Hibbs. 1982. Macrophage fibrinolytic activity: identification of two pathways of plasmin formation by intact cells and of a plasminogen activator inhibitor. Cell 28:653.
19. Louwrens, H. D., H. C. Kwaan, W. H. Pearce, J. S. Yao, and E. Verrusio. 1995. Plasminogen activator and plasminogen activator inhibitor expression by normal and aneurysmal human aortic smooth muscle cells in culture. Eur. J. Vasc. Endovasc. Surg. 10:289.
20. Wojta, J., M. Gallicchio, H. Zoellner, P. Hufnagl, K. Last, E. L. Filonzi, B. R. Binder, J. A. Hamilton, and K. McGrath. 1993. Thrombin stimulates expression of tissue-type plasminogen activator and plasminogen activator inhibitor type 1 in cultured human vascular smooth muscle cells. Thromb. Haemostasis 70:469.
21. Rijken, D. C., and D. Collen. 1981. Purification and characterization of the plasminogen activator secreted by human melanoma cells in culture. J. Biol. Chem. 256:7035.
22. Markus, G., S. Kohga, S. M. Camiolo, J. M. Madeja, J. L. Ambrus, and C. Karakousis. 1984. Plasminogen activators in human malignant melanoma. J. Natl. Cancer Inst. 72:1213.
23. Varani, J., P. E. McKeever, S. E. Fligiel, and R. G. Sitrin. 1987. Plasminogen activator production by human tumor cells: effects on tumor-extracellular matrix interactions. Int. J. Cancer 40:772.
24. Galli, S. J. 1990. Biology of disease: Mew insights into "the riddle of the mast cells:" microenvironmental regulation of mast cell development and phenotypic heterogeneity. Lab. Invest. 62:5.
25. Dvorak, A. M. 1992. Basophils and mast cells: piecemeal degranulation in situ and ex vivo: possible mechanism for cytokine-induced function in disease. In Granulocyte Responses to Cytokines, Vol. 1. R. G. Coffey, ed. Marcel Dekker, New York. p. 169.
26. Schwartz, L. B. 1985. The mast cell. In Allergy, Vol. 1. A. P. Kaplan, ed. Churchill Livingston, Edinburgh, p. 53.
27. Yano, H., B. K. Wershil, N. Arizono, and S. J. Galli. 1989 Substance P-induced augmentation of cutaneous vascular permeability and granulocyte infiltration in mice is mast cell-dependent. J. Clin. Invest. 84:1276.
28. Zhang, Y., B. F. Ramos, and B. A. Jakschik. 1992. Neutrophil recruitment by tumor necrosis factor from mast cells in immune complex peritonitis. Science 258:1957.
29. Klein, L. M., R. M. Lavker, W. L. Matis, and G. F. Murphy. 1989. Degranulation of human mast cells induces an endothelial cell antigen central to leukocyte adhesion. Proc. Natl. Acad. Sci. USA 86:8972.
30. Malaviya, R., T. Ikeda, E. Ross, and S. N. Abraham. 1996. Mast cell modulation of neutrophil influx and bacterial clearance at sites of infection through TNF-α. Nature 381:77.
31. Serafin, W. E., and K. F. Austen. 1987. Mediators of immediate hypersensitivity reactions. N. Engl. J. Med. 317:30.
32. Irani, A. M., N. M. Schechter, S. S. Craig, G. Deblois, and L. B. Schwartz. 1986. Two human mast cell subsets with distinct neutral protease compositions. Proc. Natl. Acad. Sci. USA 83:4064.
33. Plaut, M., J. H. Pierce, C. J. Watson, J. Hanle-Hyde, R. P. Nordan, and W. E. Paul. 1989. Mast cell lines produce lymphokines in response to cross-linkage of Fc epsilon RI or to calcium ionophores. Nature 339:64.
34. Burd, P. R., H. W. Rogers, J. R. Gordon, C. A. Martin, S. Jayaraman, S. D. Wilson, A. M. Dvorak, S. J. Galli, and M. E. Dorf. 1989. Interleukin 3-dependent and -independent mast cells stimulated with IgE and antigen express multiple cytokines. J. Exp. Med. 170:245.
35. Mayrhofer, G., S. J. Gadd, L. D. J. Spargo, and L. K. Ashman. 1987. Specificity of a mouse monoclonal antibody raised against acute myeloid leukemia cells for mast cells in human mucosal and connective tissues. Immunol. Cell Biol. 65:241.
36. Schulman, E. S., D. W. MacGlashan, S. P. Peters, R. P. Schleimer, H. H. Newball, and L. M. Lichtenstein. 1982. Lung mast cells: purification and characterization. J. Immunol. 129:2662.
37. Willheim, M., H. Agis, W. R. Sperr, M. Koeller, H. C. Bankl, H. Kiener, G. Fritsch, W. Fuereder, A. Spittler, W. Graninger, et al. 1995. Purification of human basophils and mast cells by multistep separation technique and mAb to CDw17 and CD117/c-kit. J. Immunol. Methods 182:115.
38. Kapiotis, S., J. Besemer, D. Bevec, P. Valent, P. Bettelheim, K. Lechner, and W. Speiser. 1991. Interleukin-4 counteracts pyrogen-induced downregulation of thrombomodulin in cultured human vascular endothelial cells. Blood 77:410.
39. Maciag, T., G. A. Hoover, M. B. Stemerman, and R. Wellnstein. 1984. Factors which stimulate the growth of human umbilical vein endolheliat cells in culture. In Biology of Endothelial Cells, Vol. 1. E. A. Jaffe, ed. Martinus Nijhoff, Dortrecht. p. 87.
40. Butterfield, J. H., D. Weiler, G. Dewald, and G. J. Gleich. 1988. Establishment of an immature mast cell line from a patient with mast cell leukemia. Leuk. Res. 12:345.
41. Kishi, K. 1985. A new leukemic cell line with Philadelphia chromosome characterized as basophil precursors. Leuk. Res. 9:381.
42. Chirgwin, J. M., A. E. Przybyla, R. J. MacDonald, and W. J. Rutter. 1979. Isolation of biologically active RNA from sources enriched in ribonuclease. Biochemistry 18:5294.
43. Valent, P., D. Bevec, D. Maurer, J. Besemer, F. Di Padova, J. H. Butterfield, W. Speiser, O. Majdic, K. Lechner, and P. Bettelheim. 1991. Interleukin 4 promotes expression of mast cell 1CAM-1 antigen. Proc. Natl. Acad. Sci. USA 88: 3339.
44. Wojta, J., R. Beckmann, L. Turcu, O. F. Wagner, A. J. van Zonneveld, and B. R. Binder. 1989. Functional characterization of monoclonal antibodies directed against fibrin binding domains of tissue-type plasminogen activator. J. Biol. Chem. 264:7957.
45. Wojta, J., B. R. Binder, K. Huber, and R. L. Hoover. 1989. Evaluation of fibrinolytic capacity in plasma during thrombolytic therapy with single (scu-PA) or two-chain urokinase type plasminogen activator (tcu-PA) by a combined assay system for urokinase type plasminogen activator antigen and function. Thromb. Haemostasis 61:289.
46. Carroll, V. A., M. R. Griffiths, M. Geiger, C. Merlo, M. Furlan, B. Lammle, and B. R. Binder. 1997. Plasma protein C inhibitor is elevated in survivors of myocardial infarction. Arterioscler. Thromb. Vasc. Biol. 17:114.
47. Geiger, M., and B. R. Binder. 1984. Plasminogen activation in diabetes mellitus: kinetic analysis of plasmin formation using components isolated from the plasma of diabetic donors. J. Biol. Chem. 259:2976.
48. Mahmoud, M., and P. J. Gaffney. 1985. Bioimmunoassay (BIA) of tissue plasminogen activator (t-PA) and its specific inhibitor (t-PA/INH). Thromb. Haemostasis 53:356.
49. Speiser, W., E. Anders, B. R. Binder, and G. Mueller-Berghaus. 1988. Clot lysis mediated by cultured human microvascular endothelial cells. Thromb. Haemostasis 60:463.
50. Bankl, H. C., T. Radaszkiewicz, G. W. Klappacher, D. Glogar, W. R. Sperr, K. Grossschmidt, H. Bankl, K. Lechner, and P. Valent. 1995. Increase and redistribution of cardiac mast cells in auricular thrombosis: possible role of kit ligand. Circulation 91:275.
51. 125I]fibrin deposition occurs at both early and late intervals of IgE-dependent or contact sensitivity reactions elicited in mouse skin: mast cell-dependent augmentation of fibrin deposition at early intervals in combined IgE-dependent and contact sensitivity reactions. J. Immunol. 145:3719.
52. 125I-fibrin deposition in IgE-dependent immediate hypersensitivity reactions in mouse skin: demonstration of the role of mast cells using genetically mast cell-deficient mice locally reconstituted with cultured mast cells. J. Immunol. 139:2605.
53. Stack, M. S., and D. A. Johnson. 1994. Human mast cell tryptase activates single chain urinary-type plasminogen activator (pro-urokinase). J. Biol. Chem. 269: 9416.
54. Bankl, H. C., T. Radaszkiewicz, M. Baghestanian, M. R. Mehrabi, H. Bankl, K. Lechner, and P. Valent. 1997. Expression of fibrinolytic antigens in redistributed cardiac mast cells in auricular thrombosis. Hum. Pathol. 28:1283.
55. Schwartz, L. B., T. R. Badford, B. H. Littman, and B. U. Wintroub. 1985. The fibrinogenolytic activity of purified tryptase from human lung mast cells. J. Immunol. 135:2762.
56. Baghestanian, M., R. Hofbauer, H. P. Kiener, H. C. Bankl, F. Wimazal, M. Willheim, O. Scheiner, W. Füreder, M. R. Muller, D. Bevec, et al. 1997. The c-kit ligand stem cell factor and anti-IgE promote expression of monocyte chemoattractant protein 1 (MCP-1) in human lung mast cells. Blood 90:4438.
57. Stein, P. L., A. J. van-Zonneveld, H. Pannekoek, and S. Strickland. 1989. Structural domains of human tissue type plasminogen activator that confer stimulation by heparin. J. Biol. Chem. 264:15441.
58. Galli, S. J., M. Tsai, and B. K. Wershil. 1993. The c-kit receptor, stem cell factor, and mast cells: what each is teaching us about the others. Am. J. Pathol. 142:965.
59. Irani, A. M., G. Nilsson, U. Miettinen, S. S. Craig, L. K. Ashman, T. Ishizaka, K. M. Zsebo, and L. B. Schwartz. 1992. Recombinant human stem cell factor stimulates differentiation of mast cells from dispersed human fetal liver cells. Blood 80:3009.
60. Mitsui, H., T. Furitsu, A. M. Dvorak, A. M. Irani, L. B. Schwartz, N. Inagaki, M. Takei, K. Ishizaka, K. M. Zsebo, and S. Gillis. 1990. Development of human mast cells from umbilical cord blood cells by recombinant human and murine c-kit ligand. Proc. Natl. Acad. Sci. USA 90:735.
61. Valent, P., E. Spanblöchl, W. R. Sperr, C. Sillaber, K. M. Zsebo, H. Agis, H. Strobl, K. Geissler, P. Bettelheim, and K. Lechner. 1992. Induction of differentiation of human mast cells from bone marrow and peripheral blood mononuclear cells by recombinant human stem cell factor (SCF)/kit ligand (KL) in long term culture. Blood 80:2237.
62. Nilsson, G., J. H. Butterfield, K. Nilsson, and A. Siegbahn. 1994. Stem cell factor is a chemotactic factor for human mast cells. J. Immunol. 153:3717.
63. Bischoff, S. C., and C. A. Dahinden. 1992. c-Kit ligand: a unique potentiator of mediator release by human lung mast cells. J. Exp. Med. 175:237.
64. Furitsu, T., T. Tsujimura, T. Tono, H. Ikeda, H. Kitayama, U. Koshimizu, H. Sugahara, J. H. Butterfield, L. K. Ashman, Y. Kanayama, et al. 1993. Identification of mulation in the coding sequence of the proto-oncogene c-kit in a human mast cell leukemia cell line causing ligand-independent activation of c-kit product. J. Clin. Invest. 92:1736.
65. Baghestanian, M., R. Hofbauer, H. G. Kress, J. Wojta, A. Fabry, B. R. Binder, C. Kaun. M. R. Müller, M. R. Mehrabi, S. Kapiotis, et al. 1997. Thrombin augments vascular cell-dependent migration of human mast cells: role of MGF. Thromb. Haemostasis 77:577.
66. Malone, D. G., R. L. Wilder, A. M. Saavedra-Delgado, and D. D. Metcalfe. 1987. Mast cell numbers in rheumatoid synovial tissues: correlations with quantitative measures of lymphocytic infiltration and modulation by antiinflammatory therapy. Arthritis Rheum. 30:130.
67. v mutant mice to brain thromboembolism and mortality caused by intravenous injection of India ink. Am. J. Pathol. 122: 469.
68. Pennica, D., W. E. Holmes, W. J. Kohr, R. N. Harkins, G. A. Vehar, C. A. Ward, W. F. Bennett, E. Yelverton, P. H. Seeburg, H. L. Heyneker, et al. 1983. Cloning and expression of human tissue-type plasminogen activator cDNA in E. coli. Nature 301:214.
69. + RNA. Proc. Natl. Acad. Sci. USA 81:4727.
70. Ny, T., M. Sawdey, D. Lawrence, J. L. Millan, and D. J. Loskutoff. 1986. Cloning and sequence of a cDNA coding for the human β-migrating endothelial-cell-type plasminogen activator inhibitor. Proc. Natl. Acad. Sci. USA 83:6776.
71. Ye, R. D., T. C. Wun, and J. E. Sadler. 1987. cDNA cloning and expression in Escherichia coli of a plasminogen activator inhibitor from human placenta. J. Biol. Chem. 262:3718.
72. Suzuki, K., Y. Deyashiki, J. Nishioka, K. Kurachi, M. Akira, S. Yamamoto, and S. Hashimoto. 1987. Characterization of a cDNA for human protein C inhibitor: a new member of the plasma serine protease inhibitor superfamily. J. Biol. Chem. 262:611.
73. Yarden, Y., W. J. Kuang, T. Yang-Feng, L. Coussens, S. Munemitsu, T. J. Dull, E. Chen, J. Schlessinger, U. Francke, and A. Ullrich. 1987. Human proto-oncogene c-kit: a new cell surface receptor tyrosine kinase for an unidentified ligand. EMBO J. 6:3341.
74. Martin, F. H., S. V. Suggs, K. E. Langley, H. S. Lu, J. Ting, K. H. Okino, C. F. Morris, I. K. McNiece, F. W. Jacobsen, E. A. Mendiaz, et al. 1990. Primary structure and functional expression of rat and human stem cell factor DNAs. Cell 63:203.
75. Nikaido, T., A. Shimizu, N. Ishida, H. Sabe, K. Teshigawara, M. Maeda. T. Uchiyama, J. Yodoi, and T. Honjo. 1984. Molecular cloning of cDNA encoding human interleukin-2 receptor. Nature 311:631.
76. Coussens, L., C. Van Beveren, D. Smith, E. Chen, R. L. Mitchell, C. M. Isacke, I. M. Verma, and A. Ullrich. 1986. Structural alteration of viral homologue of receptor proto-oncogene fms at carboxyl terminus. Nature 320:277.
77. Ercolani, L., B. Florence, M. Denaro, and M. Alexander. 1988. Isolation and complete sequence of a functional human glyceraldehyde-3-phosphate dehydro-genase gene. J. Biol. Chem. 263:15335.